U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07531043) titled 'An Evaluation of the Efficacy and Safety of FID 123472 Ophthalmic Solution for the Reduction of Ocular Redness' on April 09.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness due to minor eye irritations.
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Ocular Hyperemia
Intervention:
DRUG: Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free
Investigational ophthalmic solution applied topically to the eye in a unit dose preservative free (UDPF) formulation
DRUG: Vehicle
Inactive ingredien...